A detailed history of Los Angeles Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 11,272 shares of AMGN stock, worth $2.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,272
Previous 19,314 41.64%
Holding current value
$2.97 Million
Previous $6.03 Million 39.82%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $2.49 Million - $2.71 Million
-8,042 Reduced 41.64%
11,272 $3.63 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $14.6 Million - $17.8 Million
-55,708 Reduced 74.26%
19,314 $6.03 Million
Q1 2024

Apr 05, 2024

SELL
$268.87 - $324.56 $246 Million - $297 Million
-914,039 Reduced 92.41%
75,022 $21.3 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $134 Million - $151 Million
522,367 Added 111.93%
989,061 $285 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $50.5 Million - $62.7 Million
230,885 Added 97.91%
466,694 $125 Million
Q2 2023

Aug 03, 2023

SELL
$214.27 - $253.37 $10.1 Million - $11.9 Million
-47,025 Reduced 16.63%
235,809 $52.4 Million
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $113 Million - $138 Million
-501,232 Reduced 63.93%
282,834 $68.4 Million
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $2.46 Million - $3.13 Million
-10,747 Reduced 1.35%
784,066 $206 Million
Q3 2022

Nov 02, 2022

BUY
$224.46 - $253.15 $8.25 Million - $9.3 Million
36,747 Added 4.85%
794,813 $179 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $14.5 Million - $16.1 Million
62,635 Added 9.01%
758,066 $184 Million
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $39 Million - $43.1 Million
177,788 Added 34.35%
695,431 $168 Million
Q4 2021

Feb 03, 2022

BUY
$198.88 - $227.6 $81.5 Million - $93.2 Million
409,602 Added 379.12%
517,643 $116 Million
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $13.6 Million - $15.9 Million
-63,951 Reduced 37.18%
108,041 $23 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $1.39 Million - $1.55 Million
-5,966 Reduced 3.35%
171,992 $41.9 Million
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $6.06 Million - $7.06 Million
27,302 Added 18.12%
177,958 $44.3 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $8.98 Million - $10.7 Million
-41,491 Reduced 21.59%
150,656 $34.6 Million
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $76.8 Million - $85.4 Million
-327,184 Reduced 63.0%
192,147 $48.8 Million
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $2.58 Million - $3.16 Million
13,030 Added 2.57%
519,331 $122 Million
Q1 2020

May 04, 2020

SELL
$182.24 - $241.7 $8.83 Million - $11.7 Million
-48,467 Reduced 8.74%
506,301 $103 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $54.7 Million - $70.4 Million
289,346 Added 109.01%
554,768 $134 Million
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $8.29 Million - $9.93 Million
47,593 Added 21.85%
265,422 $51.4 Million
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $43 Million - $50.4 Million
-257,692 Reduced 54.19%
217,829 $40.1 Million
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $14.9 Million - $16.8 Million
-82,530 Reduced 14.79%
475,521 $90.3 Million
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $37.5 Million - $43.7 Million
210,056 Added 60.36%
558,051 $109 Million
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $35 Million - $39.4 Million
188,766 Added 118.55%
347,995 $72.1 Million
Q2 2018

Jul 31, 2018

SELL
$166.05 - $186.51 $661,709 - $743,242
-3,985 Reduced 2.44%
159,229 $29.4 Million
Q1 2018

Apr 27, 2018

SELL
$169.43 - $198.0 $1.55 Million - $1.81 Million
-9,165 Reduced 5.32%
163,214 $27.8 Million
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $67 Million - $74.8 Million
-396,793 Reduced 69.71%
172,379 $30 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $4.27 Million - $4.87 Million
25,511 Added 4.69%
569,172 $106 Million
Q2 2017

Aug 09, 2017

BUY
N/A
543,661
543,661 $93.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.